7Baggers

Prudential Financial Quarterly Cash Flow Statements Chart

Quarterly
 | 
Annual
 

Prudential Financial Quarterly Cash Flow Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
                
  cash flows from operating activities              
  net income566,000,000 742,000,000 451,000,000 1,171,000,000 1,151,000,000 -791,000,000 496,000,000 1,477,000,000 -556,000,000 -290,000,000 -572,000,000 -44,000,000 1,242,000,000 1,565,000,000 
  adjustments to reconcile net income to net cash from operating activities:              
  realized investment (gains) losses1,699,000,000 730,000,000 1,844,000,000 166,000,000 308,000,000 2,402,000,000 938,000,000 -217,000,000 1,392,000,000 514,000,000 1,147,000,000 316,000,000 -878,000,000 -432,000,000 
  change in value of market risk benefits, net of related hedging (gains) losses426,000,000 351,000,000 146,000,000 297,000,000 -123,000,000 251,000,000 -16,000,000 -75,000,000       
  policy charges and fee income-502,000,000 -507,000,000 -554,000,000 -557,000,000 -571,000,000 -553,000,000 -533,000,000 -540,000,000 -617,000,000 -581,000,000 -700,000,000 -634,000,000 -572,000,000 -588,000,000 
  interest credited to policyholders’ account balances1,138,000,000 825,000,000 863,000,000 1,102,000,000 1,283,000,000 872,000,000 1,149,000,000 981,000,000 779,000,000 703,000,000 665,000,000 169,000,000 723,000,000 917,000,000 
  depreciation and amortization482,000,000 -161,000,000 -41,000,000 -26,000,000 397,000,000 -45,000,000 5,000,000 41,000,000 62,000,000 -126,000,000 170,000,000 18,000,000 117,000,000 42,000,000 
  (gains) losses on assets supporting experience-rated contractholder liabilities-218,000,000 256,000,000 166,000,000 -138,000,000 -356,000,000 -4,000,000 -288,000,000 -134,000,000 28,000,000 20,000,000 108,000,000 972,000,000 132,000,000 78,000,000 
  change in:              
  deferred policy acquisition costs-282,000,000 -375,000,000 -268,000,000 -241,000,000 -273,000,000 -215,000,000 -180,000,000 -205,000,000 -45,000,000 -47,000,000 58,000,000 266,000,000 -164,000,000 -120,000,000 
  future policy benefits and other insurance liabilities294,000,000 -205,000,000 875,000,000 -524,000,000 4,175,000,000 1,991,000,000 850,000,000 1,888,000,000 170,000,000 2,309,000,000 2,690,000,000 1,404,000,000 1,983,000,000 3,116,000,000 
  reinsurance related-balances-652,000,000 -601,000,000             
  income taxes-768,000,000 133,000,000 127,000,000 -187,000,000 203,000,000 -86,000,000 -553,000,000 357,000,000 -248,000,000 -66,000,000 -1,288,000,000 -83,000,000 -568,000,000 285,000,000 
  derivatives-254,000,000 -1,336,000,000 -289,000,000 307,000,000 267,000,000 -404,000,000 21,000,000 -354,000,000 -2,068,000,000 1,388,000,000 699,000,000 -3,000,000,000 467,000,000 573,000,000 
  other-767,000,000 -2,358,000,000 -2,215,000,000 -1,516,000,000 -1,240,000,000 -578,000,000 -665,000,000 -1,876,000,000 -422,000,000 454,000,000 -1,476,000,000 617,000,000 -209,000,000 -19,000,000 
  cash flows from (used in) operating activities1,162,000,000 -2,506,000,000 1,105,000,000 -146,000,000 5,221,000,000 2,840,000,000 1,224,000,000 1,343,000,000 -622,000,000 4,278,000,000 1,501,000,000 1,000,000 3,333,000,000 5,417,000,000 
  cash flows from investing activities              
  proceeds from the sale/maturity/prepayment of:              
  fixed maturities, available-for-sale9,340,000,000 10,959,000,000 14,938,000,000 14,107,000,000 10,794,000,000 10,509,000,000 11,056,000,000 11,178,000,000 11,972,000,000 10,215,000,000 14,396,000,000 14,240,000,000 15,809,000,000 14,037,000,000 
  fixed maturities, trading322,000,000 1,123,000,000 606,000,000 1,328,000,000 570,000,000 518,000,000 118,000,000 226,000,000 220,000,000 215,000,000 676,000,000 530,000,000 1,269,000,000 216,000,000 
  assets supporting experience-rated contractholder liabilities247,000,000 486,000,000 428,000,000 383,000,000 361,000,000 437,000,000 491,000,000 765,000,000 399,000,000 776,000,000 742,000,000 9,493,000,000 4,985,000,000 4,830,000,000 
  equity securities2,277,000,000 2,344,000,000 1,435,000,000 826,000,000 2,266,000,000 2,045,000,000 642,000,000 550,000,000 627,000,000 535,000,000 991,000,000 1,544,000,000 827,000,000 1,197,000,000 
  commercial mortgage and other loans1,715,000,000 1,947,000,000 899,000,000 1,349,000,000 1,339,000,000 1,037,000,000 830,000,000 855,000,000 1,286,000,000 1,290,000,000 1,667,000,000 1,337,000,000 3,861,000,000 1,767,000,000 
  policy loans495,000,000 461,000,000 462,000,000 592,000,000 438,000,000 439,000,000 420,000,000 460,000,000 460,000,000 409,000,000 399,000,000 470,000,000 428,000,000 500,000,000 
  other invested assets643,000,000 876,000,000 575,000,000 297,000,000 511,000,000 265,000,000 283,000,000 249,000,000 362,000,000 272,000,000 674,000,000 481,000,000 821,000,000 832,000,000 
  short-term investments8,374,000,000 5,258,000,000 7,152,000,000 8,006,000,000 7,937,000,000 9,132,000,000 8,684,000,000 6,381,000,000 10,534,000,000 9,503,000,000 10,130,000,000 10,486,000,000 8,004,000,000 8,694,000,000 
  payments for the purchase/origination of:              
  cash flows from (used in) investing activities-5,828,000,000 -5,465,000,000 -5,700,000,000 -5,340,000,000 -10,244,000,000 -2,881,000,000 -2,840,000,000 -3,303,000,000 -3,376,000,000 -1,022,000,000 -3,735,000,000 495,000,000 -5,939,000,000 -2,565,000,000 
  cash flows from financing activities              
  policyholders’ account deposits10,947,000,000 8,993,000,000 10,126,000,000 8,962,000,000 8,569,000,000 7,288,000,000 6,655,000,000 6,747,000,000 7,986,000,000 8,139,000,000 5,989,000,000 7,980,000,000 8,213,000,000 8,400,000,000 
  policyholders’ account withdrawals-4,846,000,000 -4,600,000,000 -4,681,000,000 -4,825,000,000 -4,664,000,000 -4,855,000,000 -4,199,000,000 -4,592,000,000 -5,937,000,000 -5,448,000,000 -5,515,000,000 -7,249,000,000 -7,096,000,000 -6,556,000,000 
  net change in securities sold under agreements to repurchase and cash collateral for loaned securities316,000,000 639,000,000 1,948,000,000 437,000,000 1,008,000,000 309,000,000 -1,287,000,000 -97,000,000 -1,399,000,000 341,000,000 -109,000,000 -374,000,000 152,000,000 295,000,000 
  cash dividends paid on common stock-481,000,000 -491,000,000 -469,000,000 -472,000,000 -483,000,000 -458,000,000 -460,000,000 -473,000,000 -446,000,000 -450,000,000 -455,000,000 -466,000,000 -440,000,000 -448,000,000 
  net change in financing arrangements-110,000,000 266,000,000 -40,000,000 15,000,000 -511,000,000 -80,000,000 -35,000,000 38,000,000 31,000,000 13,000,000 -263,000,000 5,000,000 189,000,000 35,000,000 
  common stock acquired-250,000,000 -246,000,000 -253,000,000 -251,000,000 -242,000,000 -250,000,000 -253,000,000 -251,000,000 -375,000,000 -375,000,000 -374,000,000 -364,000,000 -403,000,000 -859,000,000 
  common stock reissued for exercise of stock options29,000,000 28,000,000 49,000,000 46,000,000 47,000,000 28,000,000 35,000,000 28,000,000 35,000,000 29,000,000 30,000,000 69,000,000 50,000,000 37,000,000 
  proceeds from the issuance of debt69,000,000 841,000,000 145,000,000 139,000,000 1,019,000,000 167,000,000 0 495,000,000 168,000,000 1,514,000,000 0 1,024,000,000 195,000,000 2,000,000 
  repayments of debt-1,003,000,000 -191,000,000 -62,000,000 -211,000,000 -539,000,000 -344,000,000 -1,575,000,000 -29,000,000 -3,000,000 -1,057,000,000 -64,000,000 -60,000,000 -541,000,000 -994,000,000 
  proceeds from notes issued by consolidated vies185,000,000 7,000,000 641,000,000 23,000,000 159,000,000 417,000,000 8,000,000 59,000,000       
  repayments of notes issued by consolidated vies0 0 -392,000,000 0 -1,000,000 -21,000,000 -2,000,000 -16,000,000     0 0 
  cash flows from (used in) financing activities5,149,000,000 5,499,000,000 7,429,000,000 4,002,000,000 4,543,000,000 2,353,000,000 -1,015,000,000 2,129,000,000 858,000,000 2,611,000,000 1,038,000,000 426,000,000 516,000,000 -860,000,000 
  effect of foreign exchange rate changes on cash balances114,000,000 56,000,000 263,000,000 -141,000,000 -227,000,000 -77,000,000 -148,000,000 5,000,000 287,000,000 -129,000,000 -231,000,000 -86,000,000 -57,000,000 -35,000,000 
  net increase in cash, cash equivalents, restricted cash and restricted cash equivalents597,000,000 -2,416,000,000 3,097,000,000 -1,625,000,000 -707,000,000 2,235,000,000 -2,779,000,000 174,000,000 -2,853,000,000 5,738,000,000 278,000,000 1,202,000,000 -2,719,000,000 458,000,000 
  cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of year0 18,520,000,000 0 0 19,463,000,000 0 0 17,299,000,000 0 0 0 12,934,000,000 0 0 
  cash, cash equivalents, restricted cash and restricted cash equivalents, end of period597,000,000 16,104,000,000 3,097,000,000 -1,625,000,000 18,756,000,000 2,235,000,000 -2,779,000,000 17,473,000,000  5,738,000,000 278,000,000 14,136,000,000  458,000,000 
  fixed maturities, held-to-maturity  0 0 0 5,000,000 10,000,000 7,000,000 14,000,000 7,000,000 8,000,000 9,000,000 84,000,000 11,000,000 
  dispositions, net of cash disposed     0   0 0   0 0 
  net increase in cash, cash equivalents, restricted cash and restricted cash equivalents including balances classified as held-for-sale     2,235,000,000 -2,779,000,000 174,000,000 -2,853,000,000 5,738,000,000 -1,427,000,000 836,000,000 -2,147,000,000  
  net change in cash balances classified as held-for-sale     0 0 0 0 0 -1,705,000,000 -366,000,000 572,000,000  
  goodwill impairment              
  cash, cash equivalents, restricted cash and restricted cash equivalents, end of year              
  acquisitions, net of cash acquired              
  non-cash transactions during the period              
  treasury stock shares issued for stock-based compensation programs              
  significant pension risk transfer transactions:              
  assets received, excluding cash and cash equivalents              
  liabilities assumed              
  net cash received              
  reconciliation to the unaudited interim consolidated statements of financial position              
  cash and cash equivalents              
  restricted cash and restricted cash equivalents              
  total cash, cash equivalents, restricted cash and restricted cash equivalents              
  conversion of surplus notes into common stock              
  net increase in cash, cash equivalents restricted cash and restricted cash equivalents              
  cash, cash equivalents restricted cash and restricted cash equivalents, beginning of year              
  cash, cash equivalents restricted cash and restricted cash equivalents, end of period              
  reconciliation to statement of financial position              
  total cash, cash equivalents restricted cash and restricted cash equivalents              
  acquisition of business, net of cash acquired              
  net increase in cash, cash equivalents restricted cash and restricted cash equivalent              
  cash, cash equivalents restricted cash and restricted cash equivalent, beginning of year              
  cash, cash equivalents restricted cash and restricted cash equivalent, end of period              
  acquisition:              
  assets acquired, excluding cash and cash equivalents              
  net cash paid on acquisition              
  (gains) losses on trading account assets supporting insurance liabilities              
  trading account assets supporting insurance liabilities and other trading account assets              
  equity securities, available-for-sale              
  other long-term investments              
  class b stock acquired              
  excess tax benefits from share-based payment arrangements              
  net increase in cash and cash equivalents              
  cash and cash equivalents, beginning of year              
  cash and cash equivalents, end of period              
  other trading account assets              
  assets acquired, excluding cash and cash equivalents acquired              
  net cash paid              
  cash dividends paid on class b stock              
  acquisition of business, net of cash acquired.              
  gains on trading account assets supporting insurance liabilities              
  acquisition of gibraltar bsn life berhad:              
  noncontrolling interest assumed              
  cash flows used in investing activities              
  acquisition of gibraltar bsn life berhad              
  acquisition of the hartford’s individual life business              
  net decrease in cash and cash equivalents              
  acquisition of uniasia life assurance berhad              

We provide you with 20 years of cash flow statements for Prudential Financial stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Prudential Financial stock. Explore the full financial landscape of Prudential Financial stock with our expertly curated income statements.

The information provided in this report about Prudential Financial stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.